Last updated: Nov 20, 2026, 12:00 AM

Genmab AS Exchange (NASDAQ, USD)

GMAB

51.35
+0.38 (+0.75%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
69.36%
3 year return (CAGR)
16.60%
5 year return (CAGR)
3.53%
10 year return (CAGR)
11.28%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
31.58B
Price/Sales
7.64
Ent value
36.63B
Price/Book
5.30
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
40.06
PEG
-
Forward P/E
32.50
EPS growth
6.29%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open51.54
Daily high52.40
Daily low50.94
Daily Volume4.34M
All-time high57.29
1y analyst estimate64.96
Beta0.55
EPS (TTM)1.28
Dividend per share0.00
Ex-div date-
Next earnings date17 Feb 2026

Ready to capitalize on Genmab AS's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
GMABS&P500
Current price drop from All-time high-10.37%-8.11%
Highest price drop-84.20%-56.47%
Date of highest drop8 Aug 20119 Mar 2009
Avg drop from high-21.97%-10.64%
Avg time to new high21 days12 days
Max time to new high1292 days1805 days